Ö¬·¾Ï¸°û·Ö»¯£¨Adipogenesis£©ÊÇÖ¬·¾Ç°Ìåϸ°ûת±äΪ³ÉÊìÖ¬·¾Ï¸°ûµÄ¹ý³Ì£¬Óë·ÊÅÖ²¡µÈ´úлÐÔ¼²²¡µÄ·¢ÉúÃÜÇÐÏà¹Ø¡£¸Ã¹ý³ÌÊÇÓÉһϵÁеÄת¼Òò×Ӹ߶ÈЭͬÍê³ÉµÄ£¬ÓɶàÖØ×ªÂ¼Ê¼þ¹¹³É¡¾1¡¿¡£Ä¿Ç°£¬Ö¬·¾Ï¸°û·Ö»¯ÖеĹؼüת¼Òò×ÓÏà¼Ì±»¼ø¶¨³öÀ´¡¾2-4¡¿£¬µ«ÊÇÖ¬·¾Ç°Ìåϸ°ûÊÇÈçºÎÕûºÏÍâ½çÐźŲ¢¿ªÆôת¼Ê¼þµÄ£¬Ä¿Ç°ÖªÖ®ÉõÉÙ¡£

DDB1 (Damage-specific DNA binding protein 1) ÊÇÒ»Öֶ๦Äܵ°°×£¬×îÔçÊÇ×÷Ϊ×ÏÍâÓÕµ¼¸´ºÏÎÓëDDB2ÐγÉÒìÔ´¶þ¾ÛÌ壩ÖеÄÒ»¸ö×é·Ö±»·¢Ïֵġ£Ä¿Ç°£¬DDB1±»¹ã·ºÈÏΪÊÇCullin 4£¨CUL4£©·ºËØÁ¬½Óø¸´ºÏÎïµÄÖØÒª¼Ü¹¹µ°°×, ͨ¹ýº¬ÓÐWD40½á¹¹ÓòµÄµ°°××÷ΪÊÊÅäÆ÷À´Ê¶±ð²¢·ºËØ»¯µ×Îïµ°°×£¬´Ó¶øµ÷¿ØÒ»ÏµÁеÄÉúÀí¹ý³Ì¡¾5-6¡¿¡£×î½üµÄÑо¿·¢ÏÖ£¬¿¹·ÊÅÖÒò×ÓWDTC1¡¾7¡¿Äܹ»Í¨¹ýCUL4À´ÒÖÖÆÖ¬·¾Ï¸°ûµÄ·Ö»¯¡¾8¡¿£¬µ«ÊÇCUL4-DDB1-WDTC1µÄµ×Îïµ°°×²¢²»Çå³þ¡£

2021Äê6ÔÂ22ÈÕ£¬¸´µ©´óѧ´úлÓëÕûºÏÉúÎïѧÑо¿ÔºÕÔͬ½ð¿ÎÌâ×éÔÚCell ReportsÔÓÖ¾ÉÏ·¢±íÁËÌâΪDDB1 Binds Histone Reader BRWD3 to Activate the Transcriptional Cascade in Adipogenesis and promote Onset of ObesityµÄÑо¿ÂÛÎÄ£¬·¢ÏÖÁËÖ¬·¾Ï¸°û·Ö»¯ÖÐDDB1Äܹ»ÒÔ²»ÒÀÀµCUL4µÄ·½Ê½¿ªÆôת¼Ê¼þµÄ·Ö×Ó»úÖÆ£¬½ÒʾÁËDDB1ÔÚµ÷¿ØÖ¬·¾×éÖ¯·¢ÓýºÍ·ÊÅÖ·¢ÉúÖеÄÉúÀí×÷Óá£

×÷ÕßÑо¿·¢ÏÖDDB1ÄÜÒÔ²»ÒÀÀµÓÚCUL4µÄÐÎʽ´Ù½øÖ¬·¾Ï¸°û·Ö»¯£¬¶øÇÒDDB1¶ÔÓÚÖ¬·¾Ï¸°û·Ö»¯×îÔçÆÚ»ùÒòµÄ±í´ïÊDZØÐèµÄ¡£½øÒ»²½Í¨¹ýRNA-SeqºÍChIp-SeqµÈÊֶΣ¬×÷Õß·¢ÏÖDDB1ÊÇͨ¹ýµ÷¿ØRNA¾ÛºÏøIIÔÝÍ£ÊÍ·Å£¨pol II pausing release£©À´¿ªÆôÖ¬·¾Ï¸°û·Ö»¯µÄת¼Æðʼʼþ¡£pol II pausing releaseµ÷¿ØºÜ¶à·¢Óý»òÓ¦¼¤Ïà¹ØµÄ¼´Ê±ÏìÓ¦»ùÒòµÄת¼¡¾9¡¿£¬µ«ÔÚÖ¬·¾Ï¸°û·Ö»¯ÖеÄ×÷Óò»Çå³þ¡£¸ÃÑо¿·¢ÏÖ£¬ÔÚûÓзֻ¯´Ì¼¤Ê±£¬DDB1Äܹ»Í¨¹ýÒÒõ£»¯×éµ°°×ÔĶÁ×ÓBRWD3½áºÏµ½×îÔçÆÚ»ùÒòÆô¶¯×ÓÉÏ¡£´Ëʱ£¬×ªÂ¼Æðʼ¸´ºÏÎïÒѾ­×é×°Íê³É£¬pol IIת¼20-60¸öºËËáºó´¦ÓÚÔÝͣ״̬£»µ±ÊÕµ½·Ö»¯ÐźŴ̼¤Ê±£¬ÕýÏòת¼ÑÓÉìÒò×Ób£¨p-TEFb£©´ÓÆäÒÖÖÆ¸´ºÏÎïÖнâÀëÊÍ·Å£¬±»DDB1ÕÐļµ½×îÔçÆÚ»ùÒòÆô¶¯×ÓÇøÓò£¬»î»¯²¢ÊÍ·ÅÔÝÍ£µÄpol II£¬´Ó¶ø¿ªÆôÁËÖ¬·¾Ï¸°û·Ö»¯µÄµÚÒ»¼¶×ªÂ¼Ê¼þ£¨Í¼1£©¡£

ͼ1£ºDDB1µ÷¿ØÖ¬·¾Ï¸°û·Ö»¯×ªÂ¼ÆðʼµÄ»úÖÆ

¸ÃÑо¿½ÒʾÁËDDB1Äܹ»ÒÔ²»ÒÀÀµÓÚCUL4µÄ·½Ê½´Ù½øÖ¬·¾Ï¸°û·Ö»¯¹ý³ÌÖÐת¼Ê¼þÆðʼµÄ·Ö×Ó»úÖÆ£¬²¢·¢ÏÖÁËpol II pausing releaseÔÚµ÷¿ØÖ¬·¾Ï¸°û·Ö»¯ÖеÄÉúÀí×÷Óá£

¸´µ©´óѧ´úлÓëÕûºÏÉúÎïѧÑо¿Ôº²©Ê¿ºóÍõÐñ£¬ÏÃÃÅ´óѧÉúÃü¿ÆÑ§Ñ§Ôº²©Ê¿ÉúÍõð©ÑࡢҩѧԺ²©Ê¿Éúºú¹úÉýΪ¸ÃÂÛÎĵĹ²Í¬µÚÒ»×÷Õߣ¬¸´µ©´óѧ´úлÓëÕûºÏÉúÎïѧÑо¿ÔºÕÔͬ½ð½ÌÊÚΪ±¾ÂÛÎĵÄͨѶ×÷Õß¡£Í¬Ê±£¬¸ÃÑо¿»ñµÃÁ˰üÀ¨¸´µ©´óѧ/Ç廪´óѧÀîÅîԺʿ¿ÎÌâ×飬ÏÃÃÅ´óѧÍõºéÎÌâ×é¡¢³ÂÓ±¿ÎÌâ×éºÍÁõÎÄ¿ÎÌâ×飬ÒÔ¼°ÉϺ£½»Í¨´óѧ»Æ¾§¿ÎÌâ×éµÄ´óÁ¦Ö§³Ö¡£

ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1016/j.celrep.2021.109281

²Î¿¼ÎÄÏ×

Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell, 2014, 156(1-2):20-44.

Siersbaek R, Nielsen R, Mandrup S. Transcriptional networks and chromatin remodeling controlling adipogenesis. Trends Endocrinol Metab, 2012, 23(2):56-64.

Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab, 2009, 20(3):107-114.

Wang W, Huang L, Huang Y, et al. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev Cell, 2009, 16(5):764-771.

Jin J, Arias EE, Chen J, et al. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell, 2006,23(5):709-721.

Angers S, Li T, Yi X, et al. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature, 2006, 443(7111):590-593.

Suh JM, Zeve D, McKay R, et al. Adipose is a conserved dosage-sensitive antiobesity gene. Cell metabolism, 2007, 6(3):195-207.

Groh BS, Yan F, Smith MD, et al. The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. EMBO Rep, 2016, 17(5):638-647.

Levine, M. paused RNA polymerase II as a developmental checkpoint. Cell, 2011, 145(4):502-511.